( @ ) Analyses failed to provide evidence of a relationship between maternal buprenorphine dose at delivery and any of the @ outcomes ( all p-values > @ ) and ( @ ) significant mean differences between the untreated ( n = @ ) and treated ( n = @ ) for NAS groups were found for duration of neonatal hospital stay and NAS peak score ( both p-values < @ ) .